PHGE

BiomX Inc.

PHGE · CIK 1739174 · Annual (10-K) · Last 7 years

Financial Trends

Revenue
20192025
Net Income−$36M
20192025
Operating CF−$26M
20192025
Free Cash Flow−$26M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue———————
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense———————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$22.19$1.47$0.51$0.95———
EPS (Diluted)$22.19$3.36$0.51$0.95———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B$0.1B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.1B
Total Liabilities——————$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.0B$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$0.0B$-0.0B$0.0B$-0.0B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B
← Companies